Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
OptimizeRx Corp
Swot
OptimizeRx Corp SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
OptimizeRx Corp has 31 Strengths, 4 Weaknesses, 3 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(31)
Weakness
(4)
Opportunity
(3)
Threats
(2)
Others
(1)
MACD Crossover Above Signal Line
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Expensive Rockets (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Turnaround Companies: Loss to Profit QoQ
Weekly Strategy: High Momentum Score Stocks (subscription)
PEG lower than Industry PEG
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Relative Outperformance versus Industry over 1 Month
MACD crossed above signal line previous end of day
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Negative to Positive growth in Sales and Profit with Strong Price momentum
Volume Shockers
High Volume, High Gain
Biggest Price Gainers from Open
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Annual net profit declining for last 2 years
Companies with Upcoming Results
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Institutions increasing their shareholding
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Promoters increasing shareholding QoQ
